what is micro dosing of glp 1 GLP-1 Microdosing: Why Taking Less Can Be Risky Micro Dosing GLP-1 After 50...?

Cresteil T

This is precisely the mechanism that contributes to the lean mass losses observed in GLP-1 clinical trials

Putting the trial numbers into perspective Historically, anti-obesity drugs produced average weight losses in the single digits (510%), and even the best options rarely approached double-digit percentages at the population level

248 The gene therapy agent AB1002, which uses the AAV2i8 vector to deliver the protein phosphatase inhibitor 1 gene, inhibits protein phosphatase 1 activity, thereby increasing the phosphorylation of phospholamban (PLN) and enhancing SERCA2a activity

This is not a miracle fat loss treatment and realistic expectations about what can be achieved are necessary

Womens health specialist, Eric Nager, M.D